Xcell Therapeutics Kosdaq

Investors are readying their return to the stock market in South Korea, encouraged by the rosy outlook for secondary battery stocks, but more retail...

Financial investment sources on Wednesday said Korea Exchange on March 31 conducted a regular review on listing more companies on the Kosdaq Global ...

South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...

South Korea’s leading secondary battery equipment player Daebo Magnetic Co. is set to sell its owner family’s controlling stake of about...

SM Entertainment Co., mired in conflict with its founder and former Chief Producer Lee Soo-man, is seeking to sell its shares in three key arms, wor...

South Korea’s health and drug safety authority has cleared Somzz to treat patients with sleep disorders, a dynamic move that is expected to vi...

South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...

Despite South Korea's Kosdaq stock market growing this month following the "January rally," individual investors in the country are still betting on...

InnoGene, which is seeking to be listed on the Kosdaq market at the end of this month, said on Wednesday that it has confirmed its offering price at...

South Korean companies are making renewed pushes to go public this year even at the expense of reduced IPO values.Zaram Technology Inc., a chip desi...

South Korea's medical diagnostics company NGeneBio Co. said on Wednesday that it is expanding its business in the Southeast Asian precision diagnost...

YLAB, a South Korean content company specializing in the production, distribution, and translation of webtoons, is moving to go public this year.Acc...

South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...

Oasis Corp., which operates the early morning food delivery platform "Oasis Market," said it passed the eligibility review for listing at Kosdaq mar...

KT Investment said on Thursday that it invested 35 billion won ($27.8 million) in 20 startups this past year, and that six invested companies succee...

Depression in equity markets in the wake of global rate hikes this year has not prevented Korean companies from rushing into Kosdaq, South Korea's m...

South Korea’s four leading biotech firms plan to launch an investment fund of up to 50 billion won ($39 million) to support smaller domestic b...

South Korea's pharmaceutical firm HLB Therapeutics Co. said on Monday that it has signed an agreement with the Korea Disease Control and Prevention ...

South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...

MDimune, a South Korean biotech company, said on Wednesday that it had signed an agreement with the Clear Vision Research (CVR) Lab, a research grou...

The Daol Financial Group is widely expected to let go of its venture capital arm in the midst of a worsening liquidity crunch. The VC firm Daol...

Peak Bio Co., a South Korean biopharmaceutical company, is debuting on the Nasdaq through a merger with US blank cheque company Ignyte Acquisition C...

The South Korean won on Monday extended losses to a fresh low since the 2008-09 financial crisis as local financial markets lost ground, alongside t...

South Korea’s e-sports company DRX is aiming to become the first e-sports firm to list on the secondary bourse Kosdaq with its planned 2024 IP...

South Korea’s diagnostic devices supplier Precision Biosensor Inc. has signed an export contract with Italian medical device company Borden Ch...

SK Discovery Co., an intermediate holding company of South Korea’s third-largest conglomerate SK Group, will take charge of the entire biotech...

Lionheart Studio Corp., South Korea’s leading game developer behind the mobile game Odin, has begun the process to go public with its July 22 ...

Samsung Biologics Co., the world’s largest contract drugmaker, plans to double its manufacturing capacity by building four additional plants w...

A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...

South Korea’s retail powerhouse Shinsegae Inc. will kickstart its efforts to build a metaverse presence, while seeking to buy a stake in its d...